Quarterly Statement Of Cash Flows

Nxera Pharma Co., Ltd. - Filing #7272710

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
2,151,000,000 JPY
-3,294,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.